Drugs Made In America Acquisition Corp.Drugs Made In America Acquisition Corp.Drugs Made In America Acquisition Corp.

Drugs Made In America Acquisition Corp.

No trades
See on Supercharts
Market capitalization
‪346.11 M‬USD
0.10USD
‪−279.85 K‬USD
0.00USD
‪28.93 M‬
Beta (1Y)
0.01
Employees (FY)
2
Revenue / Employee (1Y)
0.00USD
Net income / Employee (1Y)
‪−139.92 K‬USD

About Drugs Made In America Acquisition Corp.


Sector
CEO
Lynn Stockwell
Headquarters
Fort Lauderdale
ISIN
KYG2847J1040
FIGI
BBG01RQ5FQV1
Drugs Made In America Acquisition Corp. is a blank check company, which engages in the provision of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. The company was founded on May 23, 2024 and is headquartered in Fort Lauderdale, FL.

Check out other big names from the same industry as DMAA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
SPAQ
Horizon Kinetics SPAC Active ETF
Weight
4.06%
Market value
‪468.27 K‬
USD
ARB
Accelerate Arbitrage Fund ETF
Weight
0.80%
Market value
‪268.57 K‬
USD

Explore more ETFs 

Frequently Asked Questions


The current price of DMAA is 10.33 USD — it has increased by 0.06% in the past 24 hours. Watch Drugs Made In America Acquisition Corp. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Drugs Made In America Acquisition Corp. stocks are traded under the ticker DMAA.
DMAA stock has risen by 0.16% compared to the previous week, the month change is a 0.26% rise, over the last year Drugs Made In America Acquisition Corp. has showed a 3.47% increase.
DMAA reached its all-time high on Oct 27, 2025 with the price of 10.35 USD, and its all-time low was 9.95 USD and was reached on Feb 25, 2025. View more price dynamics on DMAA chart.
See other stocks reaching their highest and lowest prices.
DMAA stock is 0.06% volatile and has beta coefficient of 0.01. Track Drugs Made In America Acquisition Corp. stock price on the chart and check out the list of the most volatile stocks — is Drugs Made In America Acquisition Corp. there?
Yes, you can track Drugs Made In America Acquisition Corp. financials in yearly and quarterly reports right on TradingView.
DMAA net income for the last quarter is ‪2.29 M‬ USD, while the quarter before that showed ‪1.25 M‬ USD of net income which accounts for 82.42% change. Track more Drugs Made In America Acquisition Corp. financial stats to get the full picture.
No, DMAA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 17, 2025, the company has 2 employees. See our rating of the largest employees — is Drugs Made In America Acquisition Corp. on this list?
Like other stocks, DMAA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Drugs Made In America Acquisition Corp. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Drugs Made In America Acquisition Corp. technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Drugs Made In America Acquisition Corp. stock shows the strong buy signal. See more of Drugs Made In America Acquisition Corp. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.